Mechanisms and Emerging Therapeutic Targets in Skeletal Muscle Atrophy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널 순위
- KCI Q3
- 저널
- 생명과학회지36(5) · pp.437 · 2026
- 피인용
- KCI 0
- ISSN
- 1225-9918
저자
초록
Skeletal muscle atrophy-loss of mass and function-emerges with aging, immobilization, critical illness, cancer, and endocrine or neurogenic disorders. Although muscle atrophy is a hallmark of aging and numerous chronic diseases, the molecular drivers underlying its progression remain incompletely understood. Human disuse models demonstrate that early atrophy is driven primarily by declines in myofibrillar protein synthesis, while sustained wasting reflects the combined action of ubiquitin-proteasome and autophagy-lysosome pathways. In parallel, mitochondrial quality control failure caused by impaired mitophagy and endoplasmic reticulum stress integrates inflammatory and hormonal cues to depress protein translation. Simultaneously, single-cell atlases reveal fiber-type and niche-specific vulnerabilities, including denervation signatures and pro-fibrotic stromal states that help explain selective type II fiber loss with aging and disease. Interestingly, emerging evidence further implicates dysregulated lipid metabolism, particularly abnormal cholesterol homeostasis as a key contributor to muscle wasting. Intracellular cholesterol disrupts membrane integrity, impairs mitochondrial function, and activates pro-inflammatory signaling pathways within muscle fibers. Therapeutically, layered programs that pair progressive resistance exercise with protein/leucine distribution restore protein synthesis and muscle function. Furthermore, mitochondrial/UPR(unfolded protein response)-targeted agents (e.g., urolithin A) and anti-inflammatory strategies are expanding therapeutic options in select conditions. The paper offers a concise overview of the biological processes behind skeletal muscle atrophy and explores current therapeutic strategies aimed at mitigating its effects.
키워드
Autophagymitochondrial dysfunctionmuscle atrophyoxidative stress
식별자
- KCI
- ART003338484



로그인
연구물 목록으로